Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2014

View Archived Issues

Novel S1P1 receptor ligands designed by Allergan

Scientists at Purdue Pharma divulge new opioid receptors ligands

Chinese companies disclose new PI3Kalpha inhibitors

Domainex reports promising preclinical data for lead compound in model of COPD

NIH funds phase II trial of NeuroSigma's eTNS System

Biosceptre raises funds for development of BIL-221-s

Insys Therapeutics completes human abuse study for dronabinol

CNX-013-B2, a pan-PPAR activator for diabetes and obesity

Biological characterization of a first-in-class, small-molecule, anticancer kinetochore inhibitor

Kyoto Pharmaceutical's PTP-1B inhibitor, a promising candidate for diabetes and obesity

Clinical results reported for TTP-399, a liver-selective GKA for type 2 diabetes

Beloranib granted orphan drug status in the E.U. for Prader-Willi syndrome

Evzio auto-injector available in the U.S. for emergency treatment of opioid overdose

Merck & Co. discloses new Mdm2 inhibitors

Sarepta Therapeutics reports long-term data from phase IIb study of eteplirsen

Quanticel prepares novel histone demethylase inhibitors

TransTech Pharma agrees with FDA on special protocol assessment for TTP-488

Givinostat shows activity in models of glioblastoma

MabVax Therapeutics and Telik finalize merger

Baxter acquires AesRx

NDA for Kythera Biopharmaceuticals' ATX-101 accepted

Glenmark initiates first-in-human trial of MPGES-1 inhibitor

Viamet reports new phase IIa data on VT-1161 in tinea pedis and acute vulvovaginal candidiasis

Bristol-Myers Squibb plans Q3 BLA for Opdivo in advanced melanoma

Takeda plans phase I study of ixazomib citrate in lupus nephritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...